E bstein anomaly (EA) of the tricuspid valve (TV) is a rare and complex congenital cardiac malformation with a highly variable morphology, 1-3 fist described in 1866. 4 It comprises <1% of all congenital cardiac malformations and occurs in ≈1 per 200 000 live births. 5
cardiac magnetic resonance (CMR) or echocardiography. Different approaches have been reported, such as size or volume of RA or aRV and TV morphology or patency. 11, 12 A retrospective study by Tobler et al 12 described a correlation of the functional right ventricular (fRV) end-diastolic volume (EDV) and a CMR-based ratio of fRV EDV/left ventricular (LV) EDV from transversal steady state free precession (SSFP) cine images with several cardiopulmonary exercise measures. Defining the fRV in SSFP cine images is tedious because of strong interindividual variations of TV morphology and TV offset. A reliable, yet, time-consuming method to calculate individual volumes, especially of the anomalous right heart, has been demonstrated previously. 13 However, no standard segmentation rules have been set for fRV and aRV. Different groups use different definitions, either including or excluding parts of the aRV. 11, 12 This impairs accuracy and reproducibility of volume and function measurements.
We sought to define a simple and reliable CMR measure that correlates well with clinical heart failure markers, allows a classification of the severity of EA, and might also be used as a prognostic factor. To test this hypothesis, we generated in a pilot study, a new, easily acquired, end-diastolic total right/ left-volume index (total R/L-volume index) derived from CMR SSFP cine stacks. This divides the volume of the rightsided by that of the left-sided cardiac chambers. We compared the total R/L-volume index to a multitude of well-established heart failure markers.
Methods

Study Population
Fifty-eight living patients with EA were identified in the patient database of the Department of Pediatric and Adult Congenital Heart Disease, University Medical Center Goettingen, Germany. Of these, 4 patients were <10 years, 3 had implantable cardioverter-defibrillator or pacemakers, 12 patients had major corrective surgery (2 Glenn, 2 Fontan, 1 TV replacement, 7 TV reconstruction), 2 had complex-associated congenital heart defects (corrected transposition of the great arteries, double aortic arch), 1 had claustrophobia and aborted the CMR scan, 8 patients were lost in follow-up, and 8 refused to participate in the study. Some patients met multiple exclusion criteria.
Twenty-five patients remained who fulfilled the study criteria, gave written informed consent to participate in the study, and were examined prospectively within 1 day from January 2013 until July 2013 in our outpatient clinic. Inclusion criteria were EA, no TV or major cardiac corrective surgery (other than atrial septal defect closure), age >10 years, and sufficient compliance. The study protocol was approved by the local ethics committee and was in accordance with the 1975 Declaration of Helsinki.
The study protocol comprised the following: detailed medical history, clinical examination, laboratory testing, 12-channel standard ECG, 24-hour Holter ECG, cardiopulmonary exercise testing, echocardiography, and CMR. Performance of CMR was according to the guidelines in adults with congenital heart disease by the German Societies for Cardiology and Pediatric Cardiology, as well as the European Society for Cardiology. 14 Clinical examination consisted of complete physical examination, including measurement of transcutaneous oxygen saturation, blood pressure, heart rate (HR), bodyweight, and height.
Laboratory testing was conducted with standard assays from clinical routine as used by and officially certified for the Institute for Laboratory Medicine, University Medical Center, Goettingen. Measurements included full blood cell count, clinical chemistry, and brain natriuretic peptide (BNP).
Twelve-channel resting ECG was recorded at 25 mm/s using ECG ELI 250 and Veritas-Software (Mortara Instruments, Inc, Milwaukee, WI). ECG values of interest were among others HR, PQ, QRS, and QTc duration, delta wave, sings of heart block, and hypertrophy.
Twenty-four-hour Holter ECG was performed using digital Holter recorder H3+ and H-Scribe (Mortara Instruments, Inc, Milwaukee, WI). Measures of interest were HR range, origin and frequency of any abnormal rhythm, bradycardia, and HR variability.
Cardiopulmonary exercise testing was performed on a ZAN600 (nSpire Health GmbH, Oberthulba, Germany) using a ramp protocol with a total increase of 20 W/min. Respiration gas flow was measured using a ZAN VIP (Variable Impedance Pneumotachograph) flow sensor. Collected data were analyzed using ZAN-Tech Software. Relevant values were maximal power, peak oxygen uptake (peak VO 2 ), peak VO 2 /heart beat (peak O 2 pulse), expiratory volume per exhaled carbon dioxide (VE/VCO 2 ), ECG changes in repolarization, minimal and maximal HR, and minimal and maximal blood pressure.
Echocardiography comprised B-and M-mode, pulsewave and continuous wave Doppler-, Color-Doppler, as well as tissue Doppler imaging, in the standard views (short-axis, long-axis, apical 4-chamber [4CV] and 5-chamber view, subcostal long and short axis, suprajugular long and short axis) and was performed on an iE33 ultrasound system (Philips Healthcare, Leiden, The Netherlands). Measurements and videos were electronically recorded on MOD, using GE Carddas software (General Electrics, Fairfield, CT). Data analysis comprised segmentation of epicardial and endocardial borders, calculation of volume (according to Simpson method), ventricular mass, and fractional shortening, as well as ejection fraction, and was performed using OsiriX open source imaging software V3.9.4 (Pixmeo Sarl, Bernex, Switzerland), as well as Image Arena (TomTec, Unterschleißheim, Germany).
Measurements relevant for the study were fractional shortening, ejection fraction, tricuspid annular plane systolic excursion, TV offset compared with mitral valve insertion point in both systole and diastole, RA, aRV, fRV, LV, and left atrium (LA) areas in systole and diastole on 4CV, optically assessed TR (Nyquist Limit 61, gain 60%), and any abnormal morphological features or additional malformations such as septal defects.
Cardiac Magnetic Resonance
CMR scans were performed on a 1.5-Tesla MRI-Symphony scanner (Siemens Medical, Erlangen, Germany). Phased array receiver coils were used to cover the thorax. All patients were examined according to a standardized imaging protocol for EA. No sedation was applied. The protocol included among others stacks of SSFP cine images in transversal and ventricular short-axis orientation with a field of view covering all cardiac structures and great vessels, triplanar Half-Fourier Acquisition Single-Shot Turbo Spin-Echo sequences, and 2-dimensional through-plane phase contrast (PC) in flow measurements in the ascending aorta and pulmonary trunk.
Measurements of ventricular function and mass were performed using stacks of multislice-multiphase SSFP in ventricular shortaxis, as well as transversal planes, each with full coverage of both ventricles and both atria. The following features were applied: TR=14 ms, TE=2.6 ms, flip angle=20°, slice thickness=5 mm, spatial resolution 1.3×2.5 mm max, parallel imaging acceleration factor 2, 20 to 30 phases per heart cycle according to HR, with retrospective gating. Total examination time for each patient was ≈30 to 45 minutes. Segmentation of individual slices was performed for both transversal and short-axis stacks using QMass and Visia Software (Medis, Leiden, The Netherlands). The areas in 4CV were derived using OsiriX open source imaging software v3.9.4, (Pixmeo Sarl, Bernex, Switzerland). Endocardial and epicardial borders were defined manually for all patients by an experienced imager (O.H.). Contours were controlled and approved in a blinded and randomized fashion by a senior imager (M.S., 4 years of experience in CMR). In case of need for contour adjustment, expert consensus was reached among M.S., O.H., and J.L. (>10 years of experience in CMR).
Contours were drawn in end systole and end diastole for RA, aRV, fRV, LA, and LV. Volumes, mass, and ejection fraction were calculated using QMass Software (Medis, Leiden, The Netherlands).
RA, aRV, and fRV were defined as shown in Figures 1 and 2 for transversal and short-axis orientation, respectively. Segmentation followed the method described by Fratz et al. 11 Unlike the method described by Yalonetsky et al, 13 this is more tedious but describes the anatomy of EA more accurately. In the methods of Fratz et al 11 the malformed TV is traced in detail, whereas Yalonetsky et al 13 used an arbitrary line to define RA, aRV, and fRV. LV and LA segmentation in short axis followed the American Heart Association standards set by Cerqueira et al. 15 CMR flow quantification was performed in the ascending aorta and pulmonary trunk using a cine PC sequence during breath-hold. Scanner settings for these measurements were as follows: spatial resolution 1.7×1.7×5.5 mm 3 , TE/TR 3.2/75.4, flip angle 30°, encoding velocity 130 to 450 cm/s, 20 phases. The outflow tract blood flow was measured through plane in an imaging plane perpendicular to the arterial jet 1 cm distal to the valves. Magnitude and PC maps were analyzed using commercially available software (QFlow, Medis, Leiden, The Netherlands). If PC CMR flow measurements were repeated, the record with the highest peak velocity was included in the analysis. Normal reference values for the total R/L-volume index were calculated from 4 CMR studies in the literature for healthy volunteers of a similar age. [17] [18] [19] [20] 
Statistical Analysis
Statistical analysis was performed using Microsoft Excel (Microsoft Corporation, Redmond, WA) and Statistica (Stat Soft, North Melbourne, Australia) in cooperation with the Institute for Medical Statistics, University Medical Center, Goettingen, Germany. Statistical methods included descriptive measures, correlation coefficients using Pearson method for continuous variables, and Spearman rank order correlation for ordinal variables (New York Heart association classification and TR° visual) with the corresponding 95% confidence interval (using Fisher transformation) and P values of the test r=0. Bland-Altman plots were used to display the variation between transversal and short-axis view measurements. In addition, the P values of the Bland-Altman test of bias=0 are given.
Results
Data from 25 patients (72% men) who met the inclusion criteria for the study were analyzed. Mean patient age was 26±14 years, 40% were <18 years. Patient characteristics and severity of EA assessed clinically are summarized in Table 1 .
Plasma BNP levels (mean: 74±127 ng/L) were increased in 16% of patients markedly above the heart failure level (100 ng/L). Oxygen saturation was normal (>95%) in all but 1 patient.
All patients were in sinus rhythm. The QRS duration was prolonged >110 ms in 64%, QTc prolonged >440 ms in 20% of the patients. Eleven patients (44%) had a complete right bundle branch block. Performed 24-hour Holter ECG analysis showed singular supraventricular and ventricular extrasystoles but no higher grade arrhythmias.
During cardiopulmonary exercise testing, peak VO 2 /kg was decreased in 92% and VE/VCO 2 was increased in 38% of the study population.
On echocardiography, most patients (60%) exhibited a moderate to severe TR. Tricuspid annular plane systolic excursion margined from 1.7 to 5.2 cm and was reduced <2 cm in 24% and supranormal >4 cm in 16% of the study population. Biplane LV ejection fraction was decreased <60% in 15 cases (60%). 
Cardiac Magnetic Resonance
The CMR data of all 25 patients are summarized in Table 2 . A comparison of transversal and ventricular short-axis measurements using the Bland-Altman method showed significant difference only in the aRV end-diastolic volume index. In a comparison of TV offset (mm/m 2 ) and the previously described area-derived severity index ([RA+aRV]/[fRV+LA+LV]) 16 from 4CV in echocardiography and CMR, no relevant difference was found.
Severity Indices
Severity indices of EA in the study population as assessed from imaging modalities are summarized in Table 3 . Mean total R/L-volume index ([RA+aRV+fRV]/[LA+LV]) was 2.6±1.7 (limits: 1.2-7.7). Reference value for the total R/Lvolume index calculated from 4 studies with healthy volunteers in the literature 17-20 was 1.1±0.1 (limits: 1.0-1.2) for both children (8-18 years) and adults.
Correlation of different indices for severity with clinically assessed heart failure parameters is summarized in Table 4 . The CMR-derived total R/L-volume index showed relevant correlations with almost all clinically used measures of heart failure such as BNP, QRS and QTc duration, peak VO 2 /kg, peak O 2 pulse, VE/VCO 2 , systemic and pulmonary blood flow, and also with the severity of TR from both echo and CMR, as well as TV offset and tricuspid annular plane systolic excursion. These correlations are shown in Figure 3 11 showed a good correlation for calculation in transversal (P=0.0051) and short-axis views (P=0.0054).
The previously described CMR-derived score of fRV EDV/ LV EDV 12 corresponded only to some of the heart failure parameters defined above. Only a few correlations to heart failure parameters were found for the widely used TV offset (from CMR 4CV) and for the originally echo-based severity index ([RA+aRV]/[fRV+LA+LV]). 16 Moreover, we calculated an index of all right-sided to left-sided cardiac areas in echocardiography on end-diastolic 4CV, which correlated only modestly with heart failure markers, as did a modified volume severity index ([RA+aRV]/[fRV+LA+LV]; from CMR) and the index of RA/LA volumes from CMR.
Discussion
To the best of our knowledge, this is the first prospective study to define a simple index from CMR data of patients with EA and relate it with heart failure markers from different modalities such as clinical presentation, ECG, laboratory and cardiopulmonary exercise testing, and echocardiography. Currently, the timing of therapeutic interventions for EA is primarily driven by symptoms. 5, 21 The results of the present study provide an imaging-based classification of the severity of EA, which may serve as a predictive factor for the appropriate timing of therapeutic interventions in this group of patients.
We defined a total R/L-volume index that presents a simplified CMR-based correlation of cardiac function and BMI indicates body mass index; BNP, brain natriuretic peptide; BSA, body surface area; EA, Ebstein anomaly; ED, end diastolic; EF, ejection fraction; LV, left ventricle; NYHA, New York Heart association; TAPSE, tricuspid annular plane systolic excursion; TV, tricuspid valve; VE/VCO 2 , ventilatory response to carbon dioxide production at anaerobic threshold; and VO 2 , oxygen consumption. clinical severity of EA. It takes into account the overall mechanical interaction of right and left side (transversal), as well as of the atrium with the ventricle (longitudinal) of the malformed Ebstein heart. Instead of tediously tracing every individual cardiac chamber, especially on the right side of the heart, we propose to trace the right-sided cardiac chambers (ie, RA, aRV, fRV) as a whole, ignoring the malformed TV and ill-defined atrial or ventricular borders, as well as the left-sided cardiac chambers (ie, LA, LV) as a whole to obtain total volumes.
The total R/L-volume index seems to be a reliable and easy approach to assess clinical severity of EA for the following reasons: the total R/L-volume index correlates well with most heart failure markers used in clinical routine. This includes clinical presentation (New York Heart association classification), 22 laboratory tests (BNP), 23 ECG (QRS duration), 24, 25 cardiopulmonary exercise testing (peak VO 2 , VE/VCO 2 ), 12, 23 echocardiography (tricuspid annular plane systolic excursion), 26 and CMR (cardiac index). 13, 27, 28 The total R/L-volume index simplifies CMR segmentation and takes both atrioventricular (longitudinal) and left-right (transversal) interactions into account. Tobler et al 12 were the first to look at CMR functional data and several cardiopulmonary exercise measures in a retrospective study. They proposed that a score of fRV/LV EDV from CMR could help to classify the severity of EA. 12 However, the presented method to define fRV is challenging with regard to reproducibility because tracing of the TV can be difficult. 11, 13 Unlike Tobler et al, 12 our study demonstrates a correlation of CMR data to peak VO 2 and VE/VCO 2 , which in adults with congenital heart disease is regarded as a predictor of poor outcomes as hospitalization or death. 29 Previous studies have explored imaging data to reliably assess the severity of EA. However, no easy and accurate measurement has been presented to date. Currently 2 classification schemes for EA are used in echocardiography: the Severity Index by Celermajer et al 16 measures the area of the RA and aRV divided by the area of the fRV, LA, and LV ([RA+aRV]/ [fRV+LA+LV]) from 4CV. It is graded from I to IV (grade I: index <0.5, grade II: 0.5-0.99, grade III: 1.0-1.49, grade IV >1.5). A more morphological classification by Carpentier et al 30 divides EA into groups A to D by analyzing the morphology of the TV and the right-sided heart chambers. Both classifications have not been shown to correlate with peak VO 2 or other heart failure markers. 12, 23 Moreover, the Severity Index by Celermajer et al 16 calculated from our data in echocardiography and CMR 4CV correlated with only a few heart failure parameters.
We hypothesize that an important clue to understanding the altered mechanokinetics in EA is an understanding of the longitudinal (ie, base to apex or atrium to ventricle) and transversal (ie, right to left) mechanical and electric interactions of the heart chambers. Our total R/L-volume index seems to be a suitable imaging surrogate for these longitudinal and transversal functional interactions. not correlate well with heart failure parameters such as BNP or peak VO 2 . 12, 23 Within our cohort, the total R/L-volume index correlated well with the different degrees and levels of heart failure parameters described above. In addition, a comparison of the total R/Lvolume index from our study with an age-matched healthy reference group derived from the literature (Table 3) [17] [18] [19] [20] showed low, that is, normal values in healthy volunteers. Contrarily, patients with EA had a higher, that is, abnormal total R/L-volume index, in parallel with an increasing degree of heart failure.
Limitations
The study has inherent limitations of a cross sectional study with relatively small sample size. The study cohort consisted of patients with heterogeneous age. Because of the low incidence of EA, the statistical power was limited. A prospective longitudinal multicenter study would be ideal to reach a more profound statistical power and to determine the effect of the total R/L-volume index on operative timing and outcome. However, the size of our patient cohort is comparable to patient numbers in previously published studies. Furthermore, only 20% of the patients in our study cohort had a severe form of EA with overt symptoms of heart failure. PC imaging of the TV for assessment of TR was not performed in this study. PC mapping of the atrioventricular valve is generally more cumbersome and prone for errors because of the movement of the valve annulus during ventricular systole, and this issue is likely exaggerated in the Ebstein TV. Finally, we did not look at the prospective value of the proposed total R/L-volume index. Because all patients were included in a registry, we are optimistic that we could obtain the prospective data in the future.
Conclusions
In patients with EA, the CMR-derived total R/L-volume index correlated best with established heart failure parameters, as well as with the clinical status of the patient. Moreover, this total R/L-volume index is easy to obtain from either transversal or short-axis CMR stacks. We suggest that the total R/L-volume index may be used as a new and simplified CMR measure, by which the severity of EA can be assessed more reliably than by previously described severity scores. Further studies to validate the prognostic value of the total R/L-volume index are planned.
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